品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
阿拉丁 | M123328-1g | 1g | 现货 | 24644-78-8 |
4-甲基-1-茚酮 4-Methyl-1-indanone |
≥97% |
|
|
阿拉丁 | M123328-5g | 5g | 现货 | 24644-78-8 |
4-甲基-1-茚酮 4-Methyl-1-indanone |
≥97% |
|
|
阿拉丁 | M123328-250mg | 250mg | 期货,请咨询 | 24644-78-8 |
4-甲基-1-茚酮 4-Methyl-1-indanone |
≥97% |
|
|
毕得 | BD19640-1g | 1g | 现货 | 24644-78-8 |
4-甲基-2,3-二氢-1H-茚-1-酮 4-Methyl-2,3-dihydro-1H-inde... |
97% |
|
|
毕得 | BD19640-5g | 5g | 现货 | 24644-78-8 |
4-甲基-2,3-二氢-1H-茚-1-酮 4-Methyl-2,3-dihydro-1H-inde... |
97% |
|
|
毕得 | BD19640-25g | 25g | 现货 | 24644-78-8 |
4-甲基-2,3-二氢-1H-茚-1-酮 4-Methyl-2,3-dihydro-1H-inde... |
97% |
|
|
毕得 | BD19640-250mg | 250mg | 现货 | 24644-78-8 |
4-甲基-2,3-二氢-1H-茚-1-酮 4-Methyl-2,3-dihydro-1H-inde... |
97% |
|
|
乐研 | 1027130-1g | 1g | 现货 | 24644-78-8 |
4-甲基-1-茚酮 4-Methyl-2,3-dihydro-1H-inde... |
98% |
|
|
乐研 | 1027130-5g | 5g | 现货 | 24644-78-8 |
4-甲基-1-茚酮 4-Methyl-2,3-dihydro-1H-inde... |
98% |
|
|
乐研 | 1027130-10g | 10g | 现货 | 24644-78-8 |
4-甲基-1-茚酮 4-Methyl-2,3-dihydro-1H-inde... |
98% |
|
|
乐研 | 1027130-25g | 25g | 现货 | 24644-78-8 |
4-甲基-1-茚酮 4-Methyl-2,3-dihydro-1H-inde... |
98% |
|
|
乐研 | 1027130-250mg | 250mg | 现货 | 24644-78-8 |
4-甲基-1-茚酮 4-Methyl-2,3-dihydro-1H-inde... |
98% |
|
|
罗恩 | R031463-1g | 1g | 现货 | 24644-78-8 |
4-甲基-1-茚酮 4-Methyl-1-indanone |
97% |
|
|
罗恩 | R031463-5g | 5g | 现货 | 24644-78-8 |
4-甲基-1-茚酮 4-Methyl-1-indanone |
97% |
|
|
国药沃凯 | XW022464478803 | 1g | 现货 | 24644-78-8 |
4-甲基-1-茚酮 4-Methyl-2,3-dihydro-1H-inde... |
97%(沃凯) |
|
|
国药沃凯 | XW022464478802 | 250mg | 现货 | 24644-78-8 |
4-甲基-1-茚酮 4-Methyl-2,3-dihydro-1H-inde... |
97%(沃凯) |
|
|
国药沃凯 | XW022464478805 | 10g | 现货 | 24644-78-8 |
4-甲基-1-茚酮 4-Methyl-2,3-dihydro-1H-inde... |
97%(沃凯) |
|
|
国药沃凯 | XW022464478806 | 25g | 现货 | 24644-78-8 |
4-甲基-1-茚酮 4-Methyl-2,3-dihydro-1H-inde... |
97%(沃凯) |
|
|
国药沃凯 | XW022464478804 | 5g | 现货 | 24644-78-8 |
4-甲基-1-茚酮 4-Methyl-2,3-dihydro-1H-inde... |
97%(沃凯) |
|
|
麦克林2025 | M814372-1g | 1g | 5.000 | 24644-78-8 |
4-甲基-1-茚酮 4-Methyl-1-indanone |
97% |
|
|